Corporate information
Registration country
Company type
Developer of proteolytically-activated antibodiesFunding rounds
| Investor | Profile | Country | |
|---|---|---|---|
| |
Roche Venture Fund | The corporate venture fund of the healthcare company Roche |
| Investor | Profile | Country | |
|---|---|---|---|
| |
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies |
Investment activity status
Active investor